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ABSTRACT 
 
Throughout your lifetime renewable tissues and those which are exposed to prolonged 
inflammation experience an accumulation of senescent cells. These cells have previously been 
shown to acquire the senescence-associated secretory phenotype (SASP) that promotes 
proliferation and tumorigenesis of epithelial cells, thus increasing the invasive ability of tumor 
cells (1). SASP is characterized by an upregulation in mRNA levels of a number of secretory 
factors, such as growth factors, cytokines, and chemokines. It has been shown that lifetime 
exposure to oxidative stress can influence cell cytoskeleton reorganization and influence aging 
processes (2). In addition matrix metalloproteinases are key SASP factors that degrade the 
extracellular matrix (ECM), accompanying the aging process and are in part regulated by the 
production of reactive oxygen species (ROS) (2). We sought to first determine if SASP factors 
modulate the invasive properties of tumor cells as previously reported and if this process is 
redox-dependent. In addition, we questioned whether efficient antioxidant compounds, such as 
apple peel extract (APE) derived from Gala apples, that have been previously shown to contain 
several classes of polyphenolic antioxidants could modulate invasion and SASP. We have shown 
that both the invasive and migratory properties of metastatic mammary tumor cells (MDA-
MB231) can be prevented by treatment with the nutritional antioxidant, APE. Furthermore, we 
have established that the SASP-dependent regulation of tumor migration and invasion is 
impaired by treatment with APE. Overall, by gaining an understanding of the SASP by 
manipulating tumor invasion and also identifying key factors that are upregulated, future studies 
may reveal the interplay of molecular mechanisms of SASP, with the long-term goal of finding 
natural or synthetic therapies that can control the deleterious effects of this phenotype.  
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1.1 Aims of studying the Senescence Associated-Secretory Phenotype (SASP) and Invasion 
 
 As organisms age there is a correlated increase in the risk of developing a plethora of 
diseases, including several forms of cancer. Recent studies have revealed that the process of 
aging is a key component for the development of aberrant phenotypes during later stages of life. 
(1). However, in order to assess what age-related conditions, such as the tumor 
microenvironment (TME), are responsible for the onset of chronic diseases it is first important to 
understand the characteristic features of cells with limited proliferative capabilities. The aging 
cell undergoes similar physiological changes as do cancer cells due to the presence of reactive 
oxygen species (ROS), which enable both aging and cancer cells to alter their basal cellular 
interactions, promoting the development of age-associated disease and invasion of secondary 
tissues, or metastasis, respectively.  
 
1.2 Background of SASP and Redox-Dependent Invasion of Metastatic Cancer Cells 
  
 Cells undergoing cellular stress, such as DNA damage, and irradiation often initiate a 
crucial tumor-suppressor mechanism called programmed cell death, or apoptosis. Alternately, 
when cells respond to stress and halt their progression through the cell division cycle, they 
undergo the process known as replicative or cellular senescence (3). Unlike quiescent cells, 
which arrest in the G0 stage of the cell cycle and are capable of resuming proliferation in 
response to appropriate signals, senescent cells notably remain metabolically active at G1 phase 
and lack the capacity to initiate proliferation even in response to stimuli (4). The process of aging 
entails an accumulation of senescent cells through mechanisms that resist apoptosis, and it is not 
quite clear how cells determine whether to undergo the apoptotic pathway or cellular senescence 
(4).  
 Cellular senescence is induced in order to prevent cancer-prone cells from initiating 
tumorigenesis, and as such, it is recognized as a cell-autonomous tumor suppressive mechanism 
(1). However, during later stages of life cellular senescence has been suggested to contribute to 
the development of age-related diseases, and therefore, acts in both beneficial and deleterious 
manners. This phenomenon can be explained by the evolutionary theory known as antagonistic 
pleiotropy, which recognizes that fitness-promoting processes that are beneficial for an organism 
early in life may have deleterious effects at later stages of life (3). That is, since there are fewer 
aged members of the population and reproduction occurs early in life, the selective pressures of 
natural selection are not strong enough to improve the detrimental phenotypes that occur at later 
ages. 
 Recent research has identified changes in gene expression that are associated with 
senescence growth arrest. These include an increase in the mRNA levels and secretion of several 
growth factors, cytokines, and chemokines that together are referred to as the senescence-
associated secretory phenotype (SASP) (5). By assessing whether the SASP can promote the 
invasive abilities of metastatic cancer cells, further studies can identify the mechanisms by which 
these specific factors can induce tumorigenesis. Invasion of tumor cells through basement 
membranes is thought to be an essential phase in the successful formation of tumors and their 
further metastatic abilities as they development into secondary malignant growths at distant sites. 
Basement membranes are extracellular matrices (ECMs) that are made of several molecules, 
such as specific collagens, laminins, and proteoglycans (6).  
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 In order for epithelial cells to become invasive and metastasize, they must go through a 
series of steps, which begins with the loss of the cell’s polarity and detachment from the 
surrounding cells in the primary tissue. Then the tumor cell attaches to the matrix through 
increased integrin connections with the underlying ECM, and various proteases degrade the 
protein interactions that hold the matrix together, enabling the tumor cell to move throughout the 
matrix toward blood and lymphatic vessels (7). As tumor cells begin to invade lymphatic or 
vascular beds they cross the basement membrane and loose epithelial cell characteristics, in a 
process called epithelial to mesenchymal transition (EMT), which is characterized by a down-
regulation of E-cadherin, a molecule important for maintaining cell-to-cell adhesions (7). After 
the tumor cell becomes angiogenic and undergoes the EMT it can penetrate other membranes 
and colonize distant organ tissues to form secondary tumors. 
 In addition to tumor cells having the ability to promote EMT, when senescent 
fibroblasts acquire the SASP these cells become pro-inflammatory and can enhance tumor 
progression by inducing EMT (8) Both the release of soluble signaling factors, such as 
interleukins, cytokines, and growth factors, as well as secreted proteases, facilitate the disruption 
of epithelial organization and progression of pre-malignant or malignant epithelial cells by 
senescent cells. It has been shown that the secretion of high levels of IL-6 and IL-8 by senescent 
cells in breast cancer enhances the invasive capacity of this cancer cell line in cell culture. 
Additionally, conditioned media from senescent cells contains low levels of cell surface ß-
catenin and E-cadherin, which is consistent with EMT and thus, the mechanisms tumor cells 
leave the primary tumor and invade surrounding tissue (8). 
 The involvement of ROS and the redox dependency of several key factors that promote 
ECM turnover has become a growing area of research because the metastatic process has been 
identified to act as a cell death escape mechanism (7). That is, redox pathways that result in cell 
proliferation, cell motility/invasion, and glycloysis, evolved to rescue cells from oxidative 
stresses, as well as inflammation and immune attacks (7). Recently, these redox switches have 
been shown to be incorporated with ligand-dependent cascades of growth factors and ECM 
proteinases, such as MMP-1, that further promote metastatic activity (2). Therefore, by further 
investigating the redox-dependent roles of factors like MMP-1 it may be possible to develop 
therapies that can inhibit or lessen the deleterious activity that accompanies senescence-
associated oxidative stress (9).  
 Manganese superoxide dismutase (Sod2), a eukaryotic enzyme that catalyzes the 
dismutation of superoxide into hydrogen peroxide (H2O2) and oxygen (O2) in the mitochondria 
of cells has previously been defined as having tumor suppressor function because of its low level 
expression in many tumor types (10). Recently it was shown that loss of Sod2 expression is 
likely an early event in tumor progression that further results in a tumorigenic phenotype due to 
steady state increases in free radicals by Sod2 (11). Sod2 overexpression promotes the metastatic 
phenotype by producing H2O2, in the mitochondria, but if there is efficient scavenging of H2O2 
this malignant phenotype can be reversed. By using Sod2 to modulate the cellular redox-
environment the characterization of redox-dependent signaling events that drive malignancy such 
as, invasion and migration, can be accomplished. In the future, detailed studies of redox-
dependent events will enable researchers to develop targeted therapeutic interventions that can 
efficiently inhibit the redox-signaling mechanisms that are essential for metastatic progression.  
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1.3 Apple Peel Extract (APE) as a natural antioxidant and potential novel drug therapy  
The age-old saying “an apple a day keeps the doctor away” has prompted researchers to 
further understand the inverse relationship between consumption of apples and the risk of 
developing some cancers. The phytochemicals, or compounds derived from fruits and 
vegetables, which constitute the peel of an apple have been shown to contain many classes of 
polyphenolic antioxidants (12). Only a limited number of studies have evaluated the health 
benefits of apple peels. However, it has been shown that strong antioxidants that make up apple 
peels, such as quercetin and catechin, reduce cancer cell proliferation and therefore, contribute to 
apple’s anticancer activity. One study examined cellular responses in different cancer cell lines 
treated with APE (derived from Organic Gala apples) using immmunoblot analysis to examine 
PCNA, proliferative cell nuclear antigen, a biomarker for elevated proliferation indexes 
indicative of both breast and prostate cancer. Decreased PCNA activity resulted from APE 
treatment (5% and 2.5%) and this is consistent with the significant G0-G1 phase cell cycle arrest 
identified in response to APE using a cell cycle distribution assay (12).   
 We aim is to show that our freeze-dried method of APE preparation will preserve the 
inhibitory effects of the antioxidants constituting APE and effectively reduce migration in 
various cell types. In addition, we will examine changes in MMP-1 expression in APE-treated 
HT1080 fibrosarcoma cells and utilize APE treatment to observe how migration of MDA-
MB231 metastatic breast cancer cells is altered as a result of this potent antioxidant treatment. 
Further studies, using in vivo animal models to understand the molecular mechanisms by which 
APE acts as an antioxidant and potential antiproliferative treatment must be performed before 
APE can be adapted as a novel cancer or age-related disease therapy.  
 
Materials and Methods 
Figure 1.2a SASP-Driven Epithelial-Mesenchymal Transition (EMT) to Initiate 
Metastasis. (a) A senescent fibroblast in a tumor microenvironment (TME) secretes various 
factors to stimulate epithelial cell proliferation.  (b) Then the SASP-containing many factors 
(e.g., interleukins, matrix metalloproteinases (MMP) and chemokines) stimulates 
transformed cells to undergo the EMT. (c) Finally, the SASP promotes the migration, 
invasion and metastasis of mesenchymal-like cells.  
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2.1 Cells lines, media, and growing conditions 
 MDA-MB231, primary human breast adenocarcinomas, were cultured in DMEM with 
sodium pyruvate supplemented with 10% FBS, 1,000 U/mL penicillin, and 500 g/mL 
streptomycin (ATCC). IMR-90, primary human fetal lung fibroblasts were obtained from ATCC 
and cultured in MEM supplemented with 10% FBS, 1,000 U/mL penicillin, 500 g/mL 
streptomycin, and amphotericin (ATCC). HT1080, derived from a human fibrosarcoma and 
obtained from ATCC were cultured in DMEM supplemented with 10% fetal bovine serum 
(FBS), 1,000 U/mL penicillin, 500 g/mL streptomycin, and G418 antibiotic. HT1080 cells were 
engineered as follows: the CMV line had no vector transfected, an Sod2-increasing activity 
vector was transfected into HT1080 cells, giving the Sod2 cell line, and the Sod2 vecto, as well 
as a catalase vector, were transfected into HT1080 cells to give Sodcat cells that were grown 
with an additional zeocin antibiotic. 
 
Cell Growth  
 Cell lines were grown in standard cell culture conditions (37C, 5% CO2 in a 
humidified incubator) and were passaged two or three times a week to maintain them at 
subconfluent levels, depending on the cell line and confluency. Stable cell lines were generated 
for each cell line.      
 
2.2 Preparation of cDNA and RT-PCR analysis of SASP factors 
Cells to CT Kit (Invitrogen)  
The number of cells for each individual cell line (IMR90, both presenescent p<15 and 
senescent p>25, CMV, Sod2, and Sodcat) was counted and 8x103 cells/mL were seeded into a 96 
well plate. Cultured medium from wells was aspirated and 50 µL of cold (4C) 1X PBS was 
added to each well.  PBS was aspirated and 50 µL Lysis Solution was added to each sample and 
each reaction was thoroughly mixed. The lysis reaction was incubated for 5 min at room 
temperature (19-25C). 5 µL Stop solution was added to each lysis reaction and incubated at 
room temperature for 2 min. RT Master Mix was assembled using 2X SYBR RT Buffer (25 
µL/reaction), 20X RT enzyme Mix (2.5 µL/reaction), and Nuclease-free water (12.5 
µL/reaction). 40 µL RT Master Mix and sample lysate (10 µL) were added to nuclease-free PCR 
tubes. A thermal cycler set at 37˚C for 60 min, then at 95C for 5 min to denature the resulting 
cDNA.  
 
Real Time Polymerase Chain Reaction (RT-PCR) 
One tube of PCR cocktail was assembled for each gene of interest (MMP-1,IL-1, IL-8, 
MCP-1, MCP-2, GMSCF, Gro, IGF-7).The PCR cocktail consists of Power SYBR Green 
PCR Master Mix (10 µL/reaction), Forward and Reverse PCR Primers (2 µL/reaction at 10 nM) 
determined using Vector NTI, and nuclease-free water (2 µL/reaction).16 µL of PCR cocktail 
was added to 4 µL of cDNA sample. Three independent replicates were run in triplicate and β-
actin was used as the endogenous control. The plate was centrifuged for a short spin and the 
reaction was run using the Stepone Plus Real-Time PCR system (Applied Biosystem). The 
reaction was repeated for 35 cycles at 95C (20 sec) with a final extension at 60C (20 sec). The 
∆∆Ct method was followed per the manufacturer’s instructions in order to calculate fold-changes 
in expression of each target with respect to the β-actin control (Applied Biosystems).    
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Agarose gel electrophoresis 
 40 mL of ddH2O and 0.4 g of agarose were microwaved for 40 sec to make a 1% agarose 
gel solution. 1.5 µL of ethidium bromide was added and the chamber was set up by inserting a 
10-well comb at the negative terminal. The solution was poured in and left to polymerize for 15 
min. 10 µL of the 300bp-1kb exACTGene DNA ladder (Fischer) was loaded into the first well 
and the PCR products were loaded in adjacent wells from a 10 µL mix of sample and loading 
dye (1:1). The gel was run at 1000V for 35 min and visualized with the Alpha Imager under a 
UV filter.  
 
2.3 Derivation of Apple Peel Extract (APE) 
Organic (6 lbs) Gala apples were obtained and the peels were removed in a hypoxic 
tissue culture hood and placed in a sterile freeze dry container. Nitrogen gas was sprayed on the 
peels and in a lyophilizer (Labconco) the peels were freeze-dried at -82C for 48 hr. The frozen 
apple peels were homogenized and apple peel extract (APE) used for treatment was made with 
1g APE powder suspended in 10 mL basal cell culture media (10% APE). The solution was 
centrifuged at 5000 x g for 5 min and the supernatant was removed. This was repeated three 
times and the final supernatant was filter sterilized in a 0.22 µm filter (Corning), aliquoted, and 
stored at -20C.  
 
2.4 In Vitro Matrigel Invasion Assay 
The Matrigel Invasion Chamber package (BD Biocat) was brought to room temperature. 
0.5 mL of serum free media (37 ˚C) was applied to the interior of the inserts and bottom of wells. 
The inserts were left to rehydrate for 2 hr in a tissue culture incubator, at 37C, 5% CO2. 0.75 
mL of IMR90 presenescent (p<15) and senescent (p>15) conditioned media was added to the 
bottom of the insert. Then 0.5 mL of MDA-MB231 cell suspension (2.5x104 cells/mL) was 
added to the interior of the insert. The chambers were incubated for 24 hr in a humidified tissue 
culture incubator (37C, 5% CO2). A cotton-tipped swab was used to remove non-invading cells 
by applying gentle pressure across the membrane surface. Media was then aspirated and 0.5 mL 
of serum-free media was added to each well. A second repeat of swabbing was performed. 0.5 
mL of cold methanol (4C) was added to the wells adjacent to the inserts. The inserts were 
transferred into those methanol-containing wells and 0.5 mL of methanol (4C) was applied to 
the top of the inserts. Cells were fixed for 15 min at -20C and then the inserts were left to dry in 
at room temperature in a tissue culture hood for 15 min. Insert membranes were cut out with a 
razor and mounted on glass slides with DAPI mounting media (Invitrogen). Slides were left to sit 
in the dark for 15 min and then visualized using QCapture under a UV filter. The number of cells 
was counted using the freeware, ImageJ, and the ratio of presenescent cells to senescent cells 
was calculated. Statistical analysis was performed using Tukey’s Student T-test.  
 
2.5 Wound Healing Assay 
19 x 104 cells/mL (MDA-MB231, CMV, Sod2 and Sodcat cell lines) were plated in a 24-
well plate and cells were allowed to reach 80% confluency overnight. Wounding across each 
well was performed using a 10 µL pipette. Cells were then treated with 500 µL of 0% APE 
(culture media), 0.3% APE, 1% APE, and 3% APE in triplicate. Images of the wound distances 
were taken in triplicates at a designated area (drawn with a marker across the bottom of the plate) 
directly after treatment and again after 16-18 hr of treatment. Wound distances were measured 
11 
 
using the freeware, ImageJ, and the difference between the wound distance directly after 
treatment and after 16-18 hr of treatment was calculated. The calculated difference is the 
respective wound closure and the percentage of wound closure was calculated by dividing the 
average wound closure of APE-treated cells by the wound closure of untreated cells and 
multiplying by 100. Statistical analysis for the MDA-MB231 cell line was performed using 
Tukey’s Student T-test and statistical analysis was performed using one-way ANOVA for the 
CMV, Sod2, and Sodcat cell lines.  
 
 
2.6 Crystal Violet Cytoxicity Assay 
MDA-MB231 cells were plated at a density of 8,000 cells/well in a 96-well plate, 
allowed to attach overnight (24 hr), and then treated with 3% APE in a 1:3 serial dilution in 
triplicates. Control wells were not treated with APE and fresh vehicle control media was given to 
them. At this time point media was removed and 50 µL of crystal violet stain was distributed to 
the control wells and allowed to sit at room temperature for 10 min. The 96-well plate was rinsed 
in a water bath to remove excess crystal violet stain. Absorbance readings at 570 nm were taken 
using a plate reader (Tecan). After 24 hr of treatment, staining and absorbance reading were 
repeated for both control- and APE-treated cells. Statistical analysis was performed using one-
way ANOVA.  
 
 
RESULTS 
 One characteristic of many age-related degenerative diseases is enhanced extracellular 
matrix (ECM) breakdown, which is accompanied by the presence of reactive oxygen species 
(ROS) and their subsequent activation of upstream kinase cascades. Matrix metalloproteinase-1 
(MMP-1) has been found to be a major regulator for maintaining ECM turnover and the 
expression of MMP-1 is highly sensitive to the cellular redox state (9). In an effort to determine 
the effects of antioxidant therapy on redox-dependent expression of MMP-1 apple peel extract 
(APE) treatment was performed on the engineered HT1080 cell lines.  
It has been previously shown that cytotoxicity assays using APE from a freeze-drying 
method have used concentrations up to 5% APE after compound analysis determined the high 
concentration of polyphenolic antioxidants (12). By peeling the apples in a hypoxic chamber (1% 
O2) and then freeze-drying the peels, I aimed to preserve the antioxidant capacity of the APE 
treatment and therefore, a maximum concentration of 3% of the lyophilized extracts was used for 
treatment.  
RT-PCR analysis with cDNA from control no vector (CMV) cells, mitochondrial 
superoxide dismutase (Sod2) over-expressing cells (Sod2), and Sod2 over-expressing cells also 
expressing catalase (Sodcat) was performed in order to measure mRNA expression of MMP-1. 
cDNA was then derived from these three cell lines after a 24 hr treatment with 3% APE and RT-
PCR analysis was performed to observe fold changes in MMP-1 mRNA levels due to the 
antioxidant treatment. In the cells not treated wth APE there was an observed sixty-fold increase 
in MMP-1 expression in the Sod2 cell line compared to CMV cells supporting previous studies 
that found that H2O2 generated by Sod2 is required for induction of MMP-1. In addition, the 
increase in Sodcat cells have a higher level of MMP-1 expression, but because of the catalase 
vector these cells at a lower cellular redox state. Treatment with 3% APE lead to a significant 
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decrease in MMP-1 expression in both Sod2 and Sodcat cells (Fig. 3.1a), which is consist with 
the redox-dependent role of MMP-1 expression.  
 
3.1 RT-PCR data analysis  
 
 
 
 
Figure 3.1a: mRNA expression of MMP-1 is lower in Sod2, and Sodcat cell lines. 
cDNA from cells grown in culture media and cells treated with 3% APE for 24 hr were 
used in RT-PCR analysis. *= p < 0.05, **=p <0.01 in a paired Student’s T-test 
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 After my colleague confirmed the upregulation of characteristic SASP factors in 
senescent IMR90 cells in comparison to the presenescent cultures (Fig. 3.1b), I aimed to 
determine if and how the presence of these factors (released into conditioned media) affect the 
invasive capabilities of MDA-MB231 metastatic breast cancer cells. Using the in vitro Matrigel 
invasion assay as a representative model for chemoinvasion through a basement membrane, 
conditioned media cultured from presenescent (passage <15) and senescent (passage >25) cells 
were used as the chemoattractants for the cancer cells. The cells in the top of the invasion 
chamber were allowed to invade through the matrix for 24 hr and the number of cells migrating 
through was observed after DAPI staining. Figure 3.2a and Figure 3.2b depict that more MDA-
MB231 cells migrated through the chamber with media derived from senescent cells. This 
indicates that invasion of cancer cells is enhanced by the presence of inflammatory cytokines and 
interleukins, which are characteristic of the SASP that aging cells acquire.  
  
 
3.2 In vitro Matrigel Invasion Assay 
 
 
Figure 3.1b: mRNA expression of IL-1 and IL-6 is higher in IMR90 senescent 
cells (p>25) cultured in 21% O2.  
cDNA from both presenescent (p<15) and senescent cells (p>25) grown in 3 % O2 and 
21% O2 were used in RT-PCR analysis.*Data provided by Donnie McCarthy in order to 
confirm that the senescent cell conditioned media from cells have acquired the SASP. 
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Figure 3.2a: DAPI stained MDA-MB231 cells.            
Media for invasion assay chemoattractant was obtained from IMR-90 presenescent cells, 
passage #<15, (right) and senescent cells, passage #>25, (left). 
 
Figure 3.2b: Number of cells that migrated through the Matrigel membrane after a  24 
hr incubation at 37C, 5% CO2. 
Conditioned media from IMR90 senescent cells enhanced invasion through the membrane. 
**= p < 0.01 in a paired Student's T-test 
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3.3 Wound Healing Assays 
  
i. No treatment (CM) before   ii. No treatment (CM) after 18 hr  
 
  
iii. 3% APE before   iv. 3% APE after 18 hr  
 
 
 
 
 
 
 
 
 
Figure 3.3a:  Wound distances before and after 18 hr treatment of MDA-MB-231 
cells with 0% APE, culture media (CM) and 3% APE. 
Without treatment of APE, or CM alone cancer cells migrated to close the induced wound, 
while treatment with 3% APE significantly inhibited cancer cell migration to close the 
wound. Statistical analysis using Tukey’s T-test. *Arrows indicate distances measured 
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Figure 3.3b: Percentage (%) of wound closure relative to no treatment of MDA-
MB 231 cells after 18 hr treatment with different concentrations of APE. 
Higher concentrations of APE is correlated with less wound closure or less migration by 
the cancer cells **= p < 0.01 in a paired Student's T-test 
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i. CMV No treatment (CM) before    i. CMV No treatment (CM) after 18 hr  
 
  
iii. CMV 3% APE before                     iv. CMV 3% APE after 18 hr  
 
  
 
v. Sod2 No treatment (CM) before   vi. Sod2 No treatment (CM) after 18 hr  
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  vii. Sod2 3% APE before                   ix. Sod2 3% APE after 18 hr  
 
 
  
x. Sodcat No treatment (CM) before   xi. Sodcat No treatment (CM) after 18 hr  
 
  
xii. Sodcat 3% APE before      xiii. Sodcat 3% APE after 18 hr   
 
Figure 3.3c: Wound distances before and after 18 hr treatment of CMV, Sod2, and 
Sodcat cells with 0 % APE, culture media (CM) and 3% APE. 
In all three cell lines treatment with APE promoted cancer cell migration to close the 
induced wound, while 3% APE treatment significantly inhibited migration to close the 
wound. 
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 It has been determined that ECM degradation, leading to enhanced invasion and 
metastasis of MDA-MB231 cells is a redox-dependent process driven by the SASP, and my aim 
was to see if a natural antioxidant, apple peel extract (APE), could alter the migratory potential 
of various cell types. Wound healing assays are an in vitro method of measuring the change in 
distance of cell migration or percentage of wound closure. By scratching a cell monolayer of the 
different cell populations (MDA-MB231, CMV, Sod2, and Sodcat) and capturing images at the 
beginning and 18 hr after treatment both with and without 3% APE, I calculated the percentage 
of wound closure from the measured distances. It was observed that wound healing is also redox-
dependent, similar to other cell-matrix and cell-cell interactions.  
 It is evident from Figure 3.3a that 18 hr treatment with 3% APE inhibited the MDA-
MB231 cells from healing the wound. Without treatment with APE (Figure 3.3a i and ii) the cells 
migrated to close the wound almost entirely, while the 3% treated cells migrated only a small 
distance (Figure 3.3a iii and iv). We also found there to be an inverse relationship between the 
concentration of APE and the distance the cells migrated. Figure 3.3b shows that as the 
concentration of APE increased (no treatment (0%), 0.3%, 1%, 3%) the relative distance the 
MDA-MB231 cells moved to close the wound decreased. Therefore, as the antioxidant potential 
Figure 3.3d: Percentage (%) of wound closure of Sod2 and Sodcat cells relative to 
CMV migration after 18 hr treatment with different concentrations of APE. 
Higher concentrations of APE treatment combined with increased Sod2 activity is 
correlated with a smaller change in distance or less migration by the Sod2 cells 
compared to the CMV and Sodcat cell lines, ***= p< 0.001 in a one-way ANOVA test. 
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of our treatment increased the less migratory capacity these metastatic breast cancer cells 
exhibited. 
 This is also the same trend that I observed in the  HT1080-derived CMV, Sod2, and 
Sodcat cell lines, where 18 hr treatment with 3% APE inhibited all three cell lines from closing 
the wound, producing the smallest change in the induced wound distance. Figure 3.3c i-xiv show 
the images of both 0% and 3% APE before and after 18 hr treatment for CMV, Sod2, and Sodcat 
cells respectively. I have used the CMV cells as a standard in which to compare the migration of 
the Sod2 and Sodcat cells, and Figure 3.3d shows this change relative to the observed CMV 
change in distance. I infer that the overexpression of Sod2, and thus MMP-1, in the Sod2 cell 
line enabled these cells to migrate the most and nearly close the wound when only culture media 
was used as a treatment. The Sod2 cells also exhibited the largest change relative to the CMV 
cells in the 3% APE treatment, indicating that this natural antioxidant inhibited the migratory 
capacity driven by ROS in the Sod2 cells. This combinatory effect of the treatment with APE 
and the overexpression of Sod2 further illustrates how the migration of HT1080 fibrosarcomas, 
and as previously noted, metstatic breast cancer cells (MDA-MB231), is a redox-dependent 
process. In particular, the ability of Sod2 to augment MMP-1 and other essential proteins used in 
the processes of ECM degradation, invasion, and metastasis prompts future research studies 
aimed at determining how antioxidants can be used as a therapy to control the cellular redox state 
and the deleterious effects of the above cellular processes.  
 After demonstrating that APE treatment inhibited the migration of both MDA-MB231 
and HT1080-engineered cell lines, I sought to determine if this inhibition was caused by APE 
acting as an antiproliferative treatment. Figure 3.4 shows there was porliferation by untreated 
cells as indicidated by more groth from the initial growth. Alternately, higher concentrations of 
APE treatment led to more inhibition growth of the MDA-MB231 cells and it was observed that 
with 3 % APE there was about 20% cell death.  
 
 
 
3.4 Cytoxicity Assay 
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DISCUSSION 
Many people have heard the saying “an apple a day keeps the doctor away”, but 
according to a 2009 study by the Centers for Disease Control and Prevention only 33% of adults 
in the United States adults consume the recommended number of servings of fruits (3) per day. 
In addition, the potential health benefits that apples provide is concentrated in the apple peels, a 
fibrous complex rich in polyphenolic antioxidants that is often discarded by consumers. In an 
effort to assess the effects of antioxidants on the redox-dependent invasion and migration of 
cancer cells and fibroblasts, apple peel extract (APE) treatment was performed. I aimed to also 
confirm that APE has antiproliferative effects on cancer cells, and more specifically on MDA-
MB231 metastatic breast cancer cells. Although the mechanisms by which APE acts an 
antiproliferative therapy are unknown, I speculate that the complex interactions of  previously 
classified antioxidants found in APE induce its inhibitory effects (12). 
 I here demonstrate that both the invasive capacities and migratory actions of breast and 
lung cancer cell lines are redox-dependent mechanisms that can be inhibited by APE. In addition, 
we have demonstrated that the up-regulation of several inflammatory molecules, such as IL-1 
and IL-6, in senescent cells is characteristic of the SASP and this induces migration and further 
EMT of MDA-MB231 cells. Treatment with APE was effective at inhibiting migration during 
the wound healing assays in all cells lines of interest (MDA-MB231, CMV, Sod2, Sodcat) and 
when cells were treated with 3% APE this lead to an almost complete inhibition of migration, as 
indicated by the minimal % of wound closure. It is important to note that because there was 
about small level of cytotoxicity caused in the MDA-MB231 cell line with 3% APE treatment, 
the minimal wound closure observed may be affected by this cytotoxicity. However, I speculate 
that at non-toxic concentrations treatment with APE will also be effective at inhibiting the SASP-
chemotactic invasion of MDA-MB231 cells because of the similar mechanisms of cell motility. 
Through my freeze-dried method of extracting APE from Organic Gala apples I have preserved 
the inhibitory effects of APE and thus accomplished a critical step in the future utilization of 
APE or its derivatives as a therapeutic therapy.  In the future, principal compound analysis, 
including phenolic profiles and antioxidant property determination must be performed to gain a 
deeper understanding of the mechanisms by which our freeze-dry APE works to inhibit invasion, 
migration, and proliferation. 
Further studies will be aimed at confirming that APE can be used as a potential drug 
therapy for inhibiting growth of cancer cell lines as observed in the cytotoxicity assay of the 24 
hr treatment of MDA-MB231 cells with APE. In addition, it will be important to determine the 
concentration of APE treatment that does not inhibit proliferation, but does block MMP-1 
production. This will help determine if APE may be a useful treatment for delaying age-
associated diseases that are driven by the SASP and increasing longevity. Since it has been 
demonstrated that senescent cells acquire a particularly deleterious phenotype that enhances the 
migration of breast cancer cells, it is important to find natural mechanisms to delay or prevent 
the SASP and its resulting effects. It is widely known that the risk of developing most cancers 
Figure 3.4: Percentage (%) of MDA-MB231 cell growth after 24 hr treatment 
with different concentrations of APE. 
APE-untreated cells had an increase in growth while higher concentrations of APE 
correlated with an inhibition of growth. *= p< 0.05 in a one-way ANOVA test. 
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increases as we age, partly because our body's senescent cells acquire the SASP. In the future, 
APE treatment may be used to prevent ROS from accumulating and subsequently activating 
proteins responsible for ECM degradation and EMT, and therefore, in vivo studies will be aimed 
at further understanding APE and its inhibitory effects.  
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